Free Newsletter
Big pharma to close 26 more plants
Free newsletter via e-mail
Tools
Well, big pharma doesn't appear to be the safe haven for investors or employees these days. The Industrial Info Resources' Pharmaceutical Tracker has revealed that there are at least 26 plants poised for shutdown. This is in addition to those J&J, Pfizer and Schering-Plough and other layoffs we keep hearing about, and employees in pharmaceutical advertising and marketing might take the biggest hit.
Why the slump? The combination of a down economy coupled with patent expirations, negative press about popular medications, fewer prescriptions being filled and some FDA difficulties might be to blame. Continued rumors about layoffs and plant closures are unlikely to help much, either.
- read the report
- get the story in BusinessWeek
- see more at Market Watch
- here's World of DTC Marketing's take
Relate dArticles:
Fortune snubs Big Pharma in employers list
Top 8 layoffs of 2007
Pharma layoffs set new record
Comments
Post new comment
Paid Research Reports
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
- Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
- The CRO Market Outlook: Emerging markets, leading players and future trends
- Pharmaceutical Sales Force Effectiveness Strategies
- Commercial Insight: Influenza Vaccines and Antivirals - The pandemic's long-term impact
